SEB Asset Management AB Invests $647,000 in Amdocs Limited $DOX

SEB Asset Management AB acquired a new stake in Amdocs Limited (NASDAQ:DOXFree Report) during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund acquired 9,913 shares of the technology company’s stock, valued at approximately $647,000.

Other institutional investors have also modified their holdings of the company. Pzena Investment Management LLC raised its holdings in Amdocs by 82.6% in the fourth quarter. Pzena Investment Management LLC now owns 12,037,015 shares of the technology company’s stock valued at $969,100,000 after buying an additional 5,443,766 shares during the period. Alyeska Investment Group L.P. grew its stake in Amdocs by 155.1% during the fourth quarter. Alyeska Investment Group L.P. now owns 2,110,393 shares of the technology company’s stock worth $169,908,000 after buying an additional 1,283,231 shares during the period. Dimensional Fund Advisors LP grew its stake in Amdocs by 24.0% during the fourth quarter. Dimensional Fund Advisors LP now owns 2,892,761 shares of the technology company’s stock worth $232,903,000 after buying an additional 560,380 shares during the period. Squarepoint Ops LLC grew its stake in Amdocs by 469.4% during the fourth quarter. Squarepoint Ops LLC now owns 543,875 shares of the technology company’s stock worth $43,787,000 after buying an additional 448,358 shares during the period. Finally, Voloridge Investment Management LLC increased its position in shares of Amdocs by 501.1% in the fourth quarter. Voloridge Investment Management LLC now owns 520,494 shares of the technology company’s stock worth $41,905,000 after acquiring an additional 433,907 shares in the last quarter. Hedge funds and other institutional investors own 92.02% of the company’s stock.

Amdocs Stock Up 2.5%

Shares of NASDAQ:DOX opened at $52.10 on Friday. The company has a quick ratio of 0.98, a current ratio of 0.98 and a debt-to-equity ratio of 0.23. Amdocs Limited has a 52-week low of $49.74 and a 52-week high of $90.29. The company has a 50 day moving average of $55.64 and a two-hundred day moving average of $65.19. The company has a market capitalization of $5.62 billion, a price-to-earnings ratio of 10.42, a price-to-earnings-growth ratio of 0.88 and a beta of 0.41.

Amdocs (NASDAQ:DOXGet Free Report) last posted its quarterly earnings data on Thursday, May 14th. The technology company reported $1.78 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.77 by $0.01. The company had revenue of $1.17 billion for the quarter, compared to analyst estimates of $1.17 billion. Amdocs had a net margin of 11.81% and a return on equity of 19.77%. The business’s quarterly revenue was up 3.9% on a year-over-year basis. During the same quarter last year, the firm posted $1.78 earnings per share. As a group, analysts forecast that Amdocs Limited will post 6.56 earnings per share for the current fiscal year.

Amdocs Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Tuesday, June 30th will be paid a dividend of $0.569 per share. The ex-dividend date of this dividend is Tuesday, June 30th. This represents a $2.28 annualized dividend and a yield of 4.4%. Amdocs’s payout ratio is 45.60%.

Analyst Upgrades and Downgrades

DOX has been the topic of a number of research reports. Cfra downgraded shares of Amdocs to a “sell” rating in a research note on Thursday, May 14th. Stifel Nicolaus decreased their price target on shares of Amdocs from $88.00 to $71.00 and set a “buy” rating for the company in a research report on Thursday, May 14th. Wall Street Zen downgraded Amdocs from a “buy” rating to a “hold” rating in a report on Sunday, July 5th. Weiss Ratings reissued a “hold (c-)” rating on shares of Amdocs in a research report on Friday, May 8th. Finally, KeyCorp started coverage on Amdocs in a research note on Monday, June 29th. They set a “sector weight” rating on the stock. Three equities research analysts have rated the stock with a Buy rating, three have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, Amdocs presently has an average rating of “Hold” and an average target price of $86.67.

Read Our Latest Analysis on Amdocs

Amdocs Company Profile

(Free Report)

Amdocs (NASDAQ: DOX) is a global software and services provider specializing in solutions for communications, media and entertainment companies. The company designs, develops and integrates revenue management, customer experience and digital services platforms that enable service providers to launch and monetize new offerings, streamline operations and enhance subscriber engagement. Amdocs’ product suite encompasses billing and order management, customer relationship management, digital commerce and network function virtualization, supported by professional services for implementation, integration and managed operations.

Founded in 1982 and structured as a separate public company in 1998, Amdocs has its corporate headquarters in Chesterfield, Missouri, and maintains major development centers in Ra’anana, Israel.

Further Reading

Institutional Ownership by Quarter for Amdocs (NASDAQ:DOX)

Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.